These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21375436)

  • 1. Aligning the evidence with practice: NICE guidelines for drug treatment of Alzheimer's disease.
    Ballard C; Corbett A; Sharp S
    Expert Rev Neurother; 2011 Mar; 11(3):327-9. PubMed ID: 21375436
    [No Abstract]   [Full Text] [Related]  

  • 2. NICE proposes to withdraw Alzheimer's drugs from NHS.
    Kmietowicz Z
    BMJ; 2005 Mar; 330(7490):495. PubMed ID: 15746112
    [No Abstract]   [Full Text] [Related]  

  • 3. Memantine: new preparation. Poor evaluation and uncertain benefit in Alzheimer's disease.
    Prescrire Int; 2003 Dec; 12(68):203-5. PubMed ID: 14986682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H; Cummings J
    Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study notes huge costs associated with Alzheimer's disease.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Feb; 13(4):7-9. PubMed ID: 12434776
    [No Abstract]   [Full Text] [Related]  

  • 6. Drugs for Alzheimer's disease. Guidelines for prescribing cholinesterase inhibitors in Australia are similar to those in UK.
    Noble JM
    BMJ; 2001 Nov; 323(7321):1128. PubMed ID: 11725756
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving the diagnosis and treatment of Alzheimer's disease.
    Salloway S
    Med Health R I; 2006 May; 89(5):166-8. PubMed ID: 16764297
    [No Abstract]   [Full Text] [Related]  

  • 8. Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
    Gustavsson A; Van Der Putt R; Jönsson L; McShane R
    Int J Geriatr Psychiatry; 2009 Oct; 24(10):1072-8. PubMed ID: 19639600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donepezil for Alzheimer's disease.
    Sparano N
    J Fam Pract; 1998 May; 46(5):356. PubMed ID: 9597987
    [No Abstract]   [Full Text] [Related]  

  • 10. Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
    Prescrire Int; 2003 Dec; 12(68):230-1. PubMed ID: 14986699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NICE guidelines unfair for Alzheimer's disease.
    Lowery K
    Br J Nurs; 2001 Nov 8-21; 10(20):1314. PubMed ID: 11873223
    [No Abstract]   [Full Text] [Related]  

  • 12. [Questions and theses of pharmacological therapeutic options of Alzheimer's dementia with acetylcholinesterase inhibitors].
    van den Bussche H
    Z Gerontol Geriatr; 2005 Sep; 38 Suppl 1():I18-20. PubMed ID: 16189731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The post-modern world of Alzheimer's disease trials: how much is an ADAS-cog point worth in central London?
    Schneider LS
    Int J Geriatr Psychiatry; 2006 Jan; 21(1):9-13. PubMed ID: 16353164
    [No Abstract]   [Full Text] [Related]  

  • 14. Defining optimal treatment with cholinesterase inhibitors in Alzheimer's disease.
    Small G; Bullock R
    Alzheimers Dement; 2011 Mar; 7(2):177-84. PubMed ID: 21056013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivastigmine for Alzheimer's disease.
    Drug Ther Bull; 2000 Feb; 38(2):15-6. PubMed ID: 10829350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The costs of Alzheimer's disease treatment: the rationale of acetylcholinesterase inhibitors use?].
    Sobów TM; Kłoszewska I
    Psychiatr Pol; 1999; 33(5):761-7. PubMed ID: 10761441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years of cholinesterase inhibitors.
    Rodda J; Walker Z
    Int J Geriatr Psychiatry; 2009 May; 24(5):437-42. PubMed ID: 19367617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficult times for Alzheimer's treatments.
    O'Neill MF
    Drug Discov Today; 2005 Oct; 10(20):1333-5. PubMed ID: 16253864
    [No Abstract]   [Full Text] [Related]  

  • 20. Alzheimer's disease: the role of tacrine therapy.
    Jogerst G
    Iowa Med; 1995 Oct; 85(10):409-11. PubMed ID: 7591656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.